A study of glioma tissue to learn what makes these tumors different
Original title: Metabolomics and Transcriptomics of Low- and High-Grade Gliomas
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study has no phase listed, and it is looking at tumor tissue rather than testing a treatment.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study looks closely at brain tumor tissue to find new tumor groups.
Who this trial is for. This study is for people with a low grade or high grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary who are having surgery to remove it. A small piece of the removed tumor is studied to look at its chemical and gene activity. The study also tries to grow better lab and animal models of these tumors.
Where it stands. This study has not reported results. It is measuring the chemical and gene profile of each tumor. The goal is to see if new tumor groups show up that help explain why patients do so differently. The answer is not in yet.
What this means, and what it doesn't
What it could mean: This study does not add any procedures beyond the normal care for these tumors. The tissue studied is tissue that was already going to be removed. Someone who fits might ask their care team about it.
What it doesn't mean: This does not mean a new treatment is ready. A study is a test, not proven care. Joining one is not a promise that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, September 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.